Next-generation IgG protease candidate Xork to be licensed for development with AT845, an investigational Astellas Gene Therapies' product, for the treatment of Pompe Disease Selecta to receive a $10M ...
Selecta Biosciences Inc. joined a licensing agreement with Takeda Pharmaceutical Co. Ltd. to develop AAV-driven gene therapies for two lysosomal storage disorders that could bring Watertown, ...
WE TAKE the same infectious delight over Christmas lanterns, Christmas songs, Christmas trees, Christmas colors, Christmas lights — and numerous other traditional symbols of the season. It, of course, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results